Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
The Kulwicki Driver Development Program has officially announced that it is now accepting applications for the 2026 season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback